Updated from 12:56 p.m. EDT
( DISK) soared 21.1% Friday after BTP Acquisition, a group lead by film financier and producer David Bergstein, agreed to buy the film distributor for $4.40 a share, a 27% premium to Thursday's closing price. The $132 million deal should close by July 31. Shares of the Chatsworth, Calif., company closed up 73 cents to $4.19.
Magma Design Automation
( LAVA), a Mountain View, Calif., semiconductor, gained on word it had settled a patent-infringement suit brought by
for $12.5 million. Other terms weren't disclosed. Magma shares rose $1.74, or 17%, to $11.96. Synopsys was lately up 12 cents to $26.23.
( GMTN) bested Wall Street estimates for the quarter ended Feb. 3. Income totaled $15.3 million, or 85 cents a share -- which, excluding a one-off 50-cent per-share charge, crushes the 97-cent consensus, according to Thomson Financial. Revenue, at $326.9 million, tops the $318.1 million consensus estimate. Shares of the outdoor-equipment retailer added $1.31, or 13.3%, to $11.16.
will sell rights and assets related to EvaMist, its proposed spray treatment for menopause symptoms, to
( KVA) for $10 million upfront, another $140 million on regulatory approval and up to $30 million in milestone payments depending on sales. California-based Vivus rose 40 cents, or 8.5%, to $5.13. KV class A shares closed off 23 cents to $24.73; its class B stock
fell 20 cents to $24.68.
All American Semiconductor
lost more than half of its value after the Miami-based electronics distributor estimated it swung to a fourth-quarter loss of $8.3 million to $9.1 million, or $2.07 to $2.26 a share, from roughly break-even last year. Revenue drooped 16.2% year over year to $95.8 million. Shares closed down $1.31 to $1.25.
plummeted 28.4% after higher-than-expected costs sharply deflated its first-quarter outlook; earnings are now estimated at 2 cents to 4 cents a share, down from 20 cents to 23 cents a share previously. Analysts are looking for 21 cents a share. The Newton, Pa., company's slightly lower sales outlook -- $115 million -- should just miss targets. Shares fell $6.95 to $17.50.
slid after the construction company posted a small fourth-quarter loss, or break-even per share, compared with last year's 3-cent per-share profit. Revenue sank 12.2% to $9.1 million. Shares of the Florida-based company slumped 17 cents, or 14.5%, to $1.00.
La Jolla Pharma
will offer 5.8 million shares at $6 a piece with an underwriters' option for another 870,000 to cover any overallotments. Shares closed down 66 cents, or 9.8%, to $6.05.
, a Clearwater, Fla., marketing-services firm, widened its fourth-quarter per-share loss to 14 cents from 3 cents last year on sales that fell 12% to $19 million. Shares were dipping 14 cents, or 5.7%, to $2.30 earlier in the day; they closed down 2 cents at $2.42.